17 Oct 2023
PCRonline @ TCT 2023 - Get the international perspective!
Everything you need to know about #TCT2023 - view these condensed take-home messages covering major late-breaking clinical trials, registries and studies
Thanks to the contribution of our team of interventional cardiologists from around the globe, view the international perspective on Late-breaking Clinical Trials and Science to be released at TCT 2023 - check out the list here!
TCT 2023 - October 23-26, 2023
Mirvat Alasnag, Luigi Biasco, Aaysha Cader, Ali Nazmi Calik, Dejan Milasinovic, Luis Ortega-Paz, Nicola Ryan, Alex Sticchi and Panos Xaplanteris will review a selection of major Late-breaking Clinical Trials and Science (LBTs) in Interventional Cardiology released at the 2023 Transcatheter Cardiovascular Therapeutics Congress (TCT 2023).
Late-breaking Clinical Trials and Science covered:
- Five-Year Clinical and Echocardiographic Outcomes from The PARTNER 3 Low-Risk Randomized Trial
- Four-Year Outcomes from the EVOLUT Low Risk Trial
- Safety and Efficacy of Left Atrial Appendage Occlusion at the Time of Transcatheter Aortic Valve Replacement - The WATCH TAVR Trial
- Initial Outcomes of the JenaValve Trilogy Transcatheter Aortic Valve Replacement System in High-Risk Patients with Symptomatic Severe Native Aortic Regurgitation (ALIGN-AR)
- Primary Outcomes of a Pivotal Multicenter Randomized Trial Comparing the AGENT Paclitaxel-Coated Ballon with Conventional Ballon Angioplasty for In-Stent Restenosis (AGENT IDE)
- Less Than 1-month Dual Antiplatelet Therapy Followed by Ticagrelor Monotherapy after Coronary Drug-Eluting Stent Implantation for Acute Coronary Syndrome: The T-PASS Randomised Trial
- Pressure-Controlled Intermittent Coronary Sinus Occlusion (PiCSO) in Acute Myocardial Infarction: The Randomized PICSO-AMI-I Trial
- A Randomized Trial of Transcatheter Tricuspid Valve Replacement in Patients With Severe Tricuspid Regurgitation: The TRISCEND Il Trial
- Quality of Life After Transcatheter Tricuspid-Valve Repair vs. Medical Therapy in Patients with Severe Tricuspid Regurgitation: Results from the Randomized TRILUMINATE Pivotal Trial
- Transcatheter versus Surgical Aortic Valve Replacement in Patients with Severe Aortic Stenosis and Small Aortic Annuli: A Randomized Clinical Trial (the VIVA Trial)
- One Year Outcomes from a Randomized Comparison of Transcatheter Edge-to-Edge Repair Systems For Degenerative MR: The CLASP IID Trial and Registry
- One-year outcomes after Amulet or Watchman/FLX device for percutaneous left atrial appendage closure: a pre-specified analysis of the SWISS-APERO randomized clinical trial
This independent TCT 2023 Coverage is available thanks to the unrestricted support of Concept Medical
